1. Home
  2. NBIX vs MKC Comparison

NBIX vs MKC Comparison

Compare NBIX & MKC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Neurocrine Biosciences Inc.

NBIX

Neurocrine Biosciences Inc.

HOLD

Current Price

$172.01

Market Cap

13.2B

Sector

Health Care

ML Signal

HOLD

Logo McCormick & Company Incorporated

MKC

McCormick & Company Incorporated

HOLD

Current Price

$52.61

Market Cap

13.2B

ML Signal

HOLD

Company Overview

Basic Information
Metric
NBIX
MKC
Founded
1992
1889
Country
United States
United States
Employees
N/A
14100
Industry
Biotechnology: Biological Products (No Diagnostic Substances)
Packaged Foods
Sector
Health Care
Consumer Staples
Exchange
Nasdaq
Nasdaq
Market Cap
13.2B
13.2B
IPO Year
1996
N/A

Fundamental Metrics

Financial Performance
Metric
NBIX
MKC
Price
$172.01
$52.61
Analyst Decision
Strong Buy
Buy
Analyst Count
22
10
Target Price
$180.91
$67.00
AVG Volume (30 Days)
1.1M
5.1M
Earning Date
05-05-2026
03-31-2026
Dividend Yield
N/A
3.80%
EPS Growth
41.95
N/A
EPS
1.91
N/A
Revenue
$161,626,000.00
N/A
Revenue This Year
$24.73
$16.24
Revenue Next Year
$13.14
$3.71
P/E Ratio
$89.54
$23.90
Revenue Growth
977.51
N/A
52 Week Low
$122.14
$44.82
52 Week High
$181.18
$73.84

Technical Indicators

Market Signals
Indicator
NBIX
MKC
Relative Strength Index (RSI) 56.82 57.28
Support Level $153.96 $45.45
Resistance Level N/A $54.71
Average True Range (ATR) 4.57 1.60
MACD -0.61 0.07
Stochastic Oscillator 49.24 72.76

Price Performance

Historical Comparison
NBIX
MKC

About NBIX Neurocrine Biosciences Inc.

Neurocrine Biosciences Inc is a biopharmaceutical firm focused on the research, development, and commercialization of treatments for neurological, psychiatric, endocrine, and immunological disorders. Its portfolio includes therapies for conditions such as tardive dyskinesia, chorea associated with Huntington's disease, classic congenital adrenal hyperplasia due to 21-hydroxylase deficiency, and treatments for endometriosis and uterine fibroids. The company also maintains a pipeline of drug candidates in various stages of clinical and preclinical development across its therapeutic areas, including small molecules, peptides, proteins, antibodies, conjugates, and gene therapies. It derives revenue from the sale of its pharmaceutical products.

About MKC McCormick & Company Incorporated

In its 135-plus-year history, McCormick has become the leading global manufacturer of spices, herbs, extracts, seasonings, and other flavorings. In addition to its namesake brand, the firm's portfolio includes Old Bay, Zatarain's, Thai Kitchen, Frank's RedHot, French's, and Cholula. This mix will be complemented by the pending addition of Unilever's food brands, primarily Knorr cooking aids and Hellmann's mayonnaise. After the deal close, the combined business is slated to generate 70% of sales from consumers and 30% from restaurants and other packaged food and beverage manufacturers. Around 40% of sales are slated to come from faster-growing emerging markets, with Europe (23%) and North America (36%) accounting for the remainder.

Share on Social Networks: